Streetbeat News

Earnings

VZ

Verizon shares are trading higher following the release of their earnings report on Monday.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 2:24 pm

PEP

PepsiCo shares are trading lower following the release of their Q1 earnings report.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 2:22 pm

PM

Philip Morris International Inc (NYSE:PM) reported a 9.7% year-on-year sales growth for Q1 FY24, with revenues of $8.793 billion surpassing analyst estimates. The company's smoke-free business contributed to 39% of total net revenues, with a notable 20.9% growth in Heated Tobacco unit shipments. Adjusted EPS of $1.50 exceeded expectations, and the company saw a slight increase in Marlboro cigarette shipments. Despite cutting its FY24 adjusted EPS outlook, Philip Morris raised its organic revenue growth guidance and saw its shares rise by 2.98% to $96.86.

Portfolio Pulse from Shivani Kumaresan

April 23, 2024 | 2:21 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo for April 23rd, 2024, provides a trade strategy for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA, based on a proprietary formula considering price, volume, and options flow. It offers detailed analysis for each asset, including potential price targets for bullish and bearish scenarios. The memo also highlights the importance of monitoring these stocks for breakouts or reversals and adjusting tactics accordingly. Additionally, it mentions upcoming economic data releases and earnings reports that could impact market volatility.

Portfolio Pulse from RIPS

April 23, 2024 | 2:17 pm

EBMT

Eagle Bancorp Montana reported a decrease in earnings and revenue for Q1 2024, with EPS dropping to $0.24 from $0.42 year-over-year, and revenue falling to $19.2M from $21.1M.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 2:17 pm

DHR

Danaher Corp (NYSE:DHR) reported a 2.5% Y/Y decrease in Q1 sales to $5.79 billion, surpassing the consensus of $5.62 billion. Non-GAAP core revenue fell by 4%, better than the expected high-single-digit decline. Operating cash flow reached $1.7 billion, with non-GAAP free cash flow at $1.4 billion. The company saw improvements in bioprocessing orders and market share gains in its molecular diagnostics business at Cepheid. Despite a drop in biotechnology sales, life sciences and diagnostic sales increased. Operating margin exceeded guidance, and Danaher maintains its fiscal year 2024 guidance, expecting a low-single-digit decline in non-GAAP core revenue. Shares rose 6.5% to $251.46.

Portfolio Pulse from Vandana Singh

April 23, 2024 | 2:13 pm

LKQ

LKQ shares dropped following a Q1 earnings miss and a reduction in its forecast for FY24, indicating potential challenges ahead for the company.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 2:01 pm

FIVE

Five Below (NASDAQ:FIVE) has been analyzed by 17 analysts, showing a mix of sentiments from bullish to bearish, with a notable shift towards a more cautious outlook in the last 30 days. The average 12-month price target for FIVE has been adjusted to $211.29, down 5.48% from the previous $223.53, reflecting lowered expectations. Analysts from firms like JP Morgan, Evercore ISI Group, and Barclays have adjusted their ratings and price targets, indicating a response to market conditions and company performance. Five Below's financial indicators such as market capitalization, revenue growth, net margin, ROE, and ROA showcase its strong market position and financial health.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 2:00 pm

BIO

DHR

TMO

Shares of life sciences tools stocks, including Danaher, are trading higher after Danaher reported strong earnings. This positive earnings report has likely contributed to increased investor confidence in the sector, leading to a rise in stock prices for companies in the same industry.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 1:58 pm

HAL

Halliburton Company (NYSE:HAL) reported a 2.2% increase in Q1 2024 revenue to $5.804 billion, surpassing expectations. Despite a decline in North American revenue, strong international performance and stock repurchases contributed to the growth. Adjusted EPS was $0.76, beating consensus. The company anticipates low double-digit revenue growth for 2024.

Portfolio Pulse from Akanksha Bakshi

April 23, 2024 | 1:55 pm